Rating History for Enliven Therapeutics (ELVN) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/16/2025 Salveen Richter New Coverage Buy
(N/A)		 37.00
(N/A)		 21.91
(29.44)		 34.37% Details